RE: Contract20 Oct 2020 11:46
"Colin has always said, We don't want to sell all of the ukrtc antibody test to the government. As we can sell for more money privately. At the first presentation months back, he told us they were in negotiations with government so that 70 - 80% goes to them and the rest to be sold privately. Now, why do you think the sell price to the government has gone up???????? The only reason will be that IF government want every test to go to them, they will have to pay more money. Gov have to pay at least 25% of the tests made at price ukrtc would have made selling privately. That's why the sell price to government is now a lot higher.
NOTE: key word government used is we need to 'secure' these tests. Reason for that is an antibody test will be needed for every vaccine. This is why this stock is derisk. Unlike the rest, this test is here to stay.
Don't listen to this half baked RegulatorUK."
Let's put a few facts into the mix...
The government funded the UK-RTC research and development. That baked in government influence over what happens down the line.
The RNS is clear. The UK-RTC needs permission from GSC to sell to third parties. Moreover, even when that permission is granted, the government retains right of first refusal. To quote the RNS: "Should that option be made available to us the UK Government maintains first right of refusal."
You claim: "Gov have to pay at least 25% of the tests made at price ukrtc would have made selling privately." That's simply nonsense. The RNS makes it clear that the "Pricing of the tests is confidential" so you cannot back up that claim.
Sign In
Follow the stocks
